Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
China-Japan Friendship Hospital
With
LinkDoc Technology (Beijing) Co. Ltd.
The trial is a multi-centre, real-world, non-interventional, observational study. The Chinese elderly pathologically diagnosed patients with early-stage non-small cell lung cancer enrolled from 2015 to 2017 who received lobectomy or segment/wedge dissection were included and the study data on patient demographic/tumor biological characteristics, and clinical treatments were retrospectively collected to evaluate effectiveness and safety of the surgeries.
Age
65–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who received surgeries from 2014 to 2017;
Patients who received lobectomy or segment/wedge dissection;
Pathologically diagnosed patients with non-small cell lung cancer;
Patients with age \>=65 years old.
You may not be if
Patients who received neoadjuvant therapy prior to surgery.